Finasteride

Propecia · Proscar

Anti-Androgen HRT TRT Oral FDA/EMA Label

Half-life

6 hr

Time to Peak

1.5 hr

Steady State

~2 days

Bioavailability

65%

Dose Range

1–5 mg

Frequency

Daily

Overview

Type II 5-alpha-reductase inhibitor. Blocks conversion of testosterone to DHT. Used for hair loss (1 mg/day) and BPH/prostate (5 mg/day). In transfem HRT, used to reduce DHT-mediated effects (body/facial hair, scalp hair loss). In TRT, used to mitigate androgenic side effects. DHT suppression persists beyond plasma clearance due to tight enzyme binding. Category X -- teratogenic.

Mechanism of Action

Selective inhibitor of type II 5-alpha-reductase. Reduces serum DHT by ~70% at 5 mg/day without affecting testosterone levels directly.

Dosing Information

Route Dose Range Half-life Tmax Frequency
Oral 1–5 mg 6 hr 1.5 hr Daily

Used in Regimens

1 regimen

Data Sources

  • FDA Label Proscar (finasteride 5 mg) FDA Prescribing Information
  • FDA Label Propecia (finasteride 1 mg) FDA Prescribing Information

Related Tools

Track Finasteride with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.